GRTP1
gene geneOn this page
Also known as FLJ22474TBC1D6
Summary
GRTP1 (growth hormone regulated TBC protein 1, HGNC:20310) is a protein-coding gene on chromosome 13q34, encoding Growth hormone-regulated TBC protein 1 (Q5TC63). May act as a GTPase-activating protein for Rab family protein(s).
Predicted to enable GTPase activator activity. Predicted to be active in cytoplasm and plasma membrane.
Source: NCBI Gene 79774 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 105 total — 1 pathogenic
- MANE Select transcript:
NM_024719
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20310 |
| Approved symbol | GRTP1 |
| Name | growth hormone regulated TBC protein 1 |
| Location | 13q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22474, TBC1D6 |
| Ensembl gene | ENSG00000139835 |
| Ensembl biotype | protein_coding |
| OMIM | 620890 |
| Entrez | 79774 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 12 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000326039, ENST00000375430, ENST00000375431, ENST00000476439, ENST00000620217, ENST00000896924, ENST00000896925, ENST00000896926, ENST00000896927, ENST00000896928, ENST00000927042, ENST00000927043, ENST00000927044
RefSeq mRNA: 4 — MANE Select: NM_024719
NM_001286732, NM_001286733, NM_001411029, NM_024719
CCDS: CCDS66591, CCDS73606, CCDS91839, CCDS9534
Canonical transcript exons
ENST00000375431 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000940358 | 113350849 | 113350973 |
| ENSE00000940359 | 113344863 | 113344959 |
| ENSE00000940360 | 113325919 | 113326091 |
| ENSE00001467056 | 113324163 | 113324577 |
| ENSE00001467058 | 113325661 | 113325846 |
| ENSE00001467065 | 113364020 | 113364130 |
| ENSE00001594382 | 113355323 | 113355481 |
| ENSE00003672850 | 113363762 | 113363910 |
Expression profiles
Bgee: expression breadth ubiquitous, 224 present calls, max score 99.32.
FANTOM5 (CAGE): breadth broad, TPM avg 4.3132 / max 116.2168, expressed in 912 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 138340 | 3.3711 | 837 |
| 138341 | 0.6674 | 421 |
| 138339 | 0.2747 | 162 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 99.32 | gold quality |
| secondary oocyte | CL:0000655 | 99.15 | gold quality |
| right lobe of liver | UBERON:0001114 | 95.56 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.30 | gold quality |
| jejunal mucosa | UBERON:0000399 | 93.67 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.74 | gold quality |
| transverse colon | UBERON:0001157 | 89.89 | gold quality |
| skin of abdomen | UBERON:0001416 | 89.10 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 89.05 | gold quality |
| colonic mucosa | UBERON:0000317 | 89.03 | gold quality |
| duodenum | UBERON:0002114 | 88.93 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 88.53 | gold quality |
| liver | UBERON:0002107 | 88.32 | gold quality |
| skin of leg | UBERON:0001511 | 87.83 | gold quality |
| small intestine | UBERON:0002108 | 87.42 | gold quality |
| esophagus mucosa | UBERON:0002469 | 87.42 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 87.25 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 86.96 | gold quality |
| upper leg skin | UBERON:0004262 | 86.62 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 86.57 | gold quality |
| zone of skin | UBERON:0000014 | 86.41 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.27 | gold quality |
| intestine | UBERON:0000160 | 86.01 | gold quality |
| left adrenal gland | UBERON:0001234 | 85.93 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 85.79 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.77 | gold quality |
| large intestine | UBERON:0000059 | 85.75 | gold quality |
| colon | UBERON:0001155 | 85.69 | gold quality |
| rectum | UBERON:0001052 | 85.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 85.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
19 targeting GRTP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-6733-3P | 99.54 | 67.80 | 1281 |
| HSA-MIR-4519 | 99.48 | 66.10 | 859 |
| HSA-MIR-548AV-3P | 99.43 | 68.50 | 1721 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-5697 | 99.39 | 67.74 | 1249 |
| HSA-MIR-133A-3P | 99.27 | 71.53 | 1270 |
| HSA-MIR-133B | 99.27 | 71.53 | 1270 |
| HSA-MIR-4650-3P | 99.01 | 68.39 | 1062 |
| HSA-MIR-518C-5P | 98.53 | 69.20 | 1640 |
| HSA-MIR-320E | 97.49 | 65.96 | 865 |
| HSA-MIR-514A-5P | 96.94 | 65.49 | 801 |
| HSA-MIR-4280 | 96.44 | 67.69 | 473 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | grtp1a | ENSDARG00000029936 |
| danio_rerio | grtp1b | ENSDARG00000030269 |
| mus_musculus | Grtp1 | ENSMUSG00000038515 |
Paralogs (45): RABGAP1 (ENSG00000011454), TBC1D22A (ENSG00000054611), TBC1D22B (ENSG00000065491), TBC1D1 (ENSG00000065882), EVI5 (ENSG00000067208), TBC1D25 (ENSG00000068354), TBC1D2 (ENSG00000095383), TBC1D10A (ENSG00000099992), SGSM3 (ENSG00000100359), TBC1D17 (ENSG00000104946), TBC1D13 (ENSG00000107021), TBC1D12 (ENSG00000108239), TBC1D9 (ENSG00000109436), TBC1D30 (ENSG00000111490), TBC1D15 (ENSG00000121749), TBC1D5 (ENSG00000131374), TBC1D14 (ENSG00000132405), TBC1D8B (ENSG00000133138), TBC1D4 (ENSG00000136111), SGSM2 (ENSG00000141258), EVI5L (ENSG00000142459), TBCK (ENSG00000145348), USP6NL (ENSG00000148429), RABGAP1L (ENSG00000152061), SGSM1 (ENSG00000167037), TBC1D21 (ENSG00000167139), TBC1D2B (ENSG00000167202), TBC1D16 (ENSG00000167291), TBC1D10B (ENSG00000169221), TBC1D10C (ENSG00000175463), TBC1D28 (ENSG00000189375), TBC1D9B (ENSG00000197226), TBC1D8 (ENSG00000204634), TBC1D26 (ENSG00000214946), TBC1D3G (ENSG00000260287), TBC1D3K (ENSG00000273513), TBC1D3H (ENSG00000274226), TBC1D3D (ENSG00000274419), TBC1D3L (ENSG00000274512), TBC1D3 (ENSG00000274611)
Protein
Protein identifiers
Growth hormone-regulated TBC protein 1 — Q5TC63 (reviewed: Q5TC63)
Alternative names: TBC1 domain family member 6
All UniProt accessions (2): Q5TC63, A0A087X0Y1
UniProt curated annotations — full annotation on UniProt →
Function. May act as a GTPase-activating protein for Rab family protein(s).
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TC63-1 | 1 | yes |
| Q5TC63-2 | 2 | |
| Q5TC63-3 | 3 |
RefSeq proteins (4): NP_001273661, NP_001273662, NP_001397958, NP_078995* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000195 | Rab-GAP-TBC_dom | Domain |
| IPR035969 | Rab-GAP_TBC_sf | Homologous_superfamily |
| IPR050302 | Rab_GAP_TBC_domain | Family |
Pfam: PF00566
UniProt features (5 total): splice variant 2, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TC63-F1 | 94.83 | 0.91 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 59 (showing top):
PEREZ_TP63_TARGETS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, chr13q34, PEREZ_TP53_AND_TP63_TARGETS, MODULE_342, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN, GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2, WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP, FIGUEROA_AML_METHYLATION_CLUSTER_6_DN, TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP
GO Biological Process (0):
GO Molecular Function (1): GTPase activator activity (GO:0005096)
GO Cellular Component (2): cytoplasm (GO:0005737), plasma membrane (GO:0005886)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
1364 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GRTP1 | SLC9D1 | Q6UWJ1 | 616 |
| GRTP1 | TBC1D22A | Q8WUA7 | 588 |
| GRTP1 | DCUN1D2 | Q6PH85 | 544 |
| GRTP1 | ADPRHL1 | Q8NDY3 | 542 |
| GRTP1 | ZNF780A | O75290 | 537 |
| GRTP1 | TBC1D5 | Q92609 | 524 |
| GRTP1 | PCID2 | Q5JVF3 | 479 |
| GRTP1 | MYOZ3 | Q8TDC0 | 475 |
| GRTP1 | MICOS10 | Q5TGZ0 | 474 |
| GRTP1 | TBC1D13 | Q9NVG8 | 474 |
| GRTP1 | TBC1D20 | Q96BZ9 | 470 |
| GRTP1 | TIMM21 | Q9BVV7 | 455 |
| GRTP1 | DHRS4 | Q9BTZ2 | 449 |
| GRTP1 | TBC1D32 | Q96NH3 | 438 |
| GRTP1 | FBXO15 | Q8NCQ5 | 427 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GJB7 | PALM3 | psi-mi:“MI:0914”(association) | 0.530 |
| FBXL19 | MED19 | psi-mi:“MI:0914”(association) | 0.530 |
| NES | RPL10 | psi-mi:“MI:0914”(association) | 0.350 |
| HLA-C | psi-mi:“MI:0914”(association) | 0.350 | |
| MAGEA3 | PALM3 | psi-mi:“MI:0914”(association) | 0.350 |
| TBRG1 | APOD | psi-mi:“MI:0914”(association) | 0.350 |
| PCDHGC3 | FYN | psi-mi:“MI:0914”(association) | 0.350 |
| GRTP1 | UBB | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (16): GRTP1 (Affinity Capture-MS), GRTP1 (Affinity Capture-MS), GRTP1 (Affinity Capture-MS), FAM63A (Affinity Capture-MS), UBB (Affinity Capture-MS), ATP2A1 (Affinity Capture-MS), GRTP1 (Affinity Capture-RNA), GRTP1 (Affinity Capture-MS), UBB (Affinity Capture-MS), GRTP1 (Affinity Capture-MS), GRTP1 (Affinity Capture-MS), GRTP1 (Affinity Capture-MS), GRTP1 (Affinity Capture-MS), FAM63A (Affinity Capture-MS), GRTP1 (Affinity Capture-MS)
ESM2 similar proteins: A0A3L7I2I8, A6H6A9, A7YWD2, O08593, O60733, O94829, P15498, P27870, P49638, P49754, P54100, P97570, P97819, Q02384, Q07889, Q07890, Q28HW9, Q2KIX2, Q2T9Q1, Q3UBZ5, Q4QQU7, Q4R678, Q5F361, Q5KU39, Q5R974, Q5TC63, Q5ZIC8, Q5ZJ17, Q62245, Q66H63, Q6AXU7, Q6GL87, Q6GLZ0, Q6NRC7, Q6PBU5, Q8AYC9, Q8BM85, Q8CA95, Q8K0C1, Q8R3D1
Diamond homologs: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A2AWA9, A3KGB4, A6H6A9, A6NDS4, A6NER0, A6QP29, B0R0W9, B7ZAP0, B9A6J9, H2KZZ6, O60343, O60447, O95759, O97790, P0C7X1, P35125, P58802, P97366, Q0IIM8, Q10496, Q12317, Q12344, Q28CB1, Q3UYK3, Q4KMP7, Q5R372, Q5RAN1, Q5RCW6, Q5SVR0, Q5TC63, Q5ZJ17, Q60949, Q66K14, Q6DHY5, Q6IPX1, Q6ZT07
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
105 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 68 |
| Likely benign | 21 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 625813 | GRCh37/hg19 13q33.1-34(chr13:101881803-115091330) | Pathogenic |
SpliceAI
1532 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:113325718:A:AC | donor_gain | 1.0000 |
| 13:113325718:AT:A | donor_gain | 1.0000 |
| 13:113325843:CTGT:C | acceptor_gain | 1.0000 |
| 13:113325914:CTCA:C | donor_loss | 1.0000 |
| 13:113325915:TCAC:T | donor_loss | 1.0000 |
| 13:113325916:CACC:C | donor_loss | 1.0000 |
| 13:113325917:A:T | donor_loss | 1.0000 |
| 13:113325918:C:CA | donor_loss | 1.0000 |
| 13:113326091:TCTGC:T | acceptor_loss | 1.0000 |
| 13:113326092:C:CC | acceptor_gain | 1.0000 |
| 13:113326100:CAA:C | acceptor_gain | 1.0000 |
| 13:113326102:A:AC | acceptor_gain | 1.0000 |
| 13:113326102:A:C | acceptor_gain | 1.0000 |
| 13:113326104:G:C | acceptor_gain | 1.0000 |
| 13:113326104:G:GC | acceptor_gain | 1.0000 |
| 13:113350969:CAGGT:C | acceptor_gain | 1.0000 |
| 13:113350974:C:CC | acceptor_gain | 1.0000 |
| 13:113363855:T:TA | donor_gain | 1.0000 |
| 13:113324573:ATTTT:A | acceptor_gain | 0.9900 |
| 13:113324574:TTTT:T | acceptor_gain | 0.9900 |
| 13:113325694:C:CA | donor_gain | 0.9900 |
| 13:113325705:T:C | donor_gain | 0.9900 |
| 13:113325718:ATCG:A | donor_gain | 0.9900 |
| 13:113325719:T:C | donor_gain | 0.9900 |
| 13:113325746:T:TA | donor_gain | 0.9900 |
| 13:113325913:GCTCA:G | donor_loss | 0.9900 |
| 13:113325917:A:AC | donor_gain | 0.9900 |
| 13:113325917:ACCT:A | donor_gain | 0.9900 |
| 13:113325918:C:CC | donor_gain | 0.9900 |
| 13:113325918:CCT:C | donor_gain | 0.9900 |
AlphaMissense
2183 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:113325828:C:G | D252H | 0.996 |
| 13:113325957:A:G | W233R | 0.996 |
| 13:113325957:A:T | W233R | 0.996 |
| 13:113344900:A:C | F175L | 0.996 |
| 13:113344900:A:T | F175L | 0.996 |
| 13:113344902:A:G | F175L | 0.996 |
| 13:113325831:A:G | W251R | 0.995 |
| 13:113325831:A:T | W251R | 0.995 |
| 13:113344951:A:C | N158K | 0.995 |
| 13:113344951:A:T | N158K | 0.995 |
| 13:113355431:A:G | W78R | 0.995 |
| 13:113355431:A:T | W78R | 0.995 |
| 13:113363807:A:G | W46R | 0.995 |
| 13:113363807:A:T | W46R | 0.995 |
| 13:113363892:G:C | F17L | 0.995 |
| 13:113363892:G:T | F17L | 0.995 |
| 13:113363894:A:G | F17L | 0.995 |
| 13:113344940:C:T | G162E | 0.994 |
| 13:113350939:G:C | F125L | 0.994 |
| 13:113350939:G:T | F125L | 0.994 |
| 13:113350941:A:G | F125L | 0.994 |
| 13:113350964:C:G | R117P | 0.994 |
| 13:113344959:C:G | G156R | 0.993 |
| 13:113344959:C:T | G156R | 0.993 |
| 13:113350857:A:G | Y153H | 0.993 |
| 13:113350892:A:G | L141P | 0.993 |
| 13:113355443:G:T | R74S | 0.993 |
| 13:113363805:C:A | W46C | 0.993 |
| 13:113363805:C:G | W46C | 0.993 |
| 13:113325827:T:A | D252V | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000003737 (13:113362403 A>G), RS1000088162 (13:113325625 C>T), RS1000105289 (13:113366029 G>A), RS1000105767 (13:113328820 C>T), RS1000125609 (13:113340149 C>A,T), RS1000181540 (13:113343327 G>C), RS1000189404 (13:113339597 T>A), RS1000227597 (13:113328226 CTG>C), RS1000371466 (13:113354604 C>G), RS1000384029 (13:113360922 C>A), RS1000415073 (13:113329039 G>A,C,T), RS1000427020 (13:113354807 G>A), RS1000588463 (13:113333315 G>A), RS1000695417 (13:113333223 T>C), RS1000757596 (13:113343521 A>G)
Disease associations
OMIM: gene MIM:620890 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001335_25 | Mean platelet volume | 8.000000e-12 |
| GCST004599_159 | Mean platelet volume | 2.000000e-40 |
| GCST004603_132 | Platelet count | 8.000000e-17 |
| GCST004616_53 | Platelet distribution width | 5.000000e-09 |
| GCST004616_54 | Platelet distribution width | 4.000000e-45 |
| GCST007998_16 | Intraocular pressure | 8.000000e-17 |
| GCST90002395_163 | Mean platelet volume | 9.000000e-48 |
| GCST90002395_165 | Mean platelet volume | 2.000000e-78 |
| GCST90002401_66 | Platelet distribution width | 2.000000e-37 |
| GCST90002401_67 | Platelet distribution width | 9.000000e-14 |
| GCST90002401_68 | Platelet distribution width | 2.000000e-86 |
| GCST90002402_224 | Platelet count | 2.000000e-22 |
| GCST90002402_225 | Platelet count | 4.000000e-50 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0007984 | platelet component distribution width |
| EFO:0004695 | intraocular pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | affects binding, increases expression, affects cotreatment, decreases expression | 4 |
| Valproic Acid | increases expression | 3 |
| methylmercuric chloride | increases expression | 2 |
| Acetaminophen | decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| Aflatoxin B1 | affects expression, increases methylation | 2 |
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression, decreases reaction | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Vehicle Emissions | decreases expression, decreases reaction | 1 |
| Cadmium | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Nickel | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | decreases expression, decreases reaction | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.